Anxiety disorders are now recognized as the largest single group of mental disorders in the United States. According to an NIMH study, 7% of the population is affected.1 Moreover, in a recent survey of training analysts done by Donovan and Roose, 64% of analysts are now using psychopharmacotherapy conjointly with psychoanalysis.2 So this reader looked forward with great expectations to this book which promised to approach the far-reaching and crucial topic of anxiety from a variety of perspectives, including psychophysiological, pharmacological, and clinical.

Roose and Glick have assembled an impressive group of thirteen contributors, nine of whom come from their department at Columbia